Literature DB >> 8070008

Synergistic effect of inhibitors of topoisomerase I and II on chromosome damage and cell killing in cultured Chinese hamster ovary cells.

F Cortés1, J Piñero.   

Abstract

Simultaneous treatment of cultured Chinese hamster ovary cells with the topoisomerase I inhibitor camptothecin and the topoisomerase II inhibitor 4'-(9-acridinylamino)-methanesulfon-m-anisidide results in a clear synergistic effect on both chromosome damage detected at metaphase and loss of colony-forming ability. In contrast, the effect of combined treatment with these topoisomerase inhibitors on sister chromatid exchanges was not significantly different from that expected if the effects were additive. Taken as a whole, these results seem to support the hypothesis that topoisomerase inhibitors can lead to cell death, presumably when DNA replication forks collide with drug-stabilized cleavable complexes. Nevertheless, no evidence of apoptosis was obtained from DNA fragmentation analysis. The possible clinical implications of our findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8070008     DOI: 10.1007/bf00685566

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  32 in total

1.  Cell death induced by topoisomerase inhibitors. Role of calcium in mammalian cells.

Authors:  R Bertrand; D Kerrigan; M Sarang; Y Pommier
Journal:  Biochem Pharmacol       Date:  1991-06-21       Impact factor: 5.858

2.  Importance of replication fork progression for the induction of chromosome damage and SCE by inhibitors of DNA topoisomerases.

Authors:  F Cortés; J Piñero; T Ortiz
Journal:  Mutat Res       Date:  1993-10       Impact factor: 2.433

Review 3.  DNA topoisomerase poisons as antitumor drugs.

Authors:  L F Liu
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

4.  Inhibition of DNA synthesis and DNA fragmentation in stimulated splenocytes by the concerted action of topoisomerase I and II poisons.

Authors:  G Taudou; C Portemer; C Jaxel; M Duguet
Journal:  Biochem Pharmacol       Date:  1993-01-26       Impact factor: 5.858

5.  X-ray-induced chromosome damage in live mammalian cells, and improved measurements of its effects on their colony-forming ability.

Authors:  G P Joshi; W J Nelson; S H Revell; C A Shaw
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1982-02

6.  Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiation.

Authors:  G Del Bino; S Bruno; P N Yi; Z Darzynkiewicz
Journal:  Cell Prolif       Date:  1992-11       Impact factor: 6.831

7.  Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864).

Authors:  M R Mattern; G A Hofmann; F L McCabe; R K Johnson
Journal:  Cancer Res       Date:  1991-11-01       Impact factor: 12.701

8.  Poly-D-lysine enhances the genotoxicity of bleomycin in cultured CHO cells.

Authors:  F Cortés; N Panneerselvam; S Mateos; T Ortiz
Journal:  Carcinogenesis       Date:  1993-12       Impact factor: 4.944

Review 9.  New natural products in cancer chemotherapy.

Authors:  W J Slichenmyer; D D Von Hoff
Journal:  J Clin Pharmacol       Date:  1990-09       Impact factor: 3.126

10.  Topoisomerase inhibitors induce irreversible fragmentation of replicated DNA in concanavalin A stimulated splenocytes.

Authors:  C Jaxel; G Taudou; C Portemer; G Mirambeau; J Panijel; M Duguet
Journal:  Biochemistry       Date:  1988-01-12       Impact factor: 3.162

View more
  3 in total

1.  Synergistic cytotoxicity, apoptosis and protein-linked DNA breakage by etoposide and camptothecin in human U87 glioma cells: dependence on tyrosine phosphorylation.

Authors:  M J Ciesielski; R A Fenstermaker
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

2.  Phase II study of XR5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with advanced ovarian cancer.

Authors:  Christian Dittrich; Veronique Dieras; Pierre Kerbrat; Cornelis Punt; Roberto Sorio; Francesco Caponigro; Xavier Paoletti; Christine de Balincourt; Denis Lacombe; Pierre Fumoleau
Journal:  Invest New Drugs       Date:  2003-08       Impact factor: 3.850

3.  Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells.

Authors:  Hai Wang; Pranay Agarwal; Shuting Zhao; Ronald X Xu; Jianhua Yu; Xiongbin Lu; Xiaoming He
Journal:  Biomaterials       Date:  2015-08-29       Impact factor: 12.479

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.